Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page
- Check6 days agoChange DetectedResults have been posted for the phase 3 study, including primary and secondary outcomes and related efficacy data.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page now displays revision v3.4.2 and the prior funding-lapse notice (v3.4.1) has been removed.SummaryDifference0.6%

- Check21 days agoChange DetectedA funding-status notice was added and the page revision updated to v3.4.1 (replacing v3.4.0). These changes are administrative and do not affect study data, eligibility, or core content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while deletions remove Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4; these are UI/metadata changes that do not alter study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedNo significant additions or deletions were detected on the study details page. The content and layout remain unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed; a technical metadata update that does not change study details or participating locations.SummaryDifference0.3%

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.